SCHEMBL2906440

SCHEMBL2906440

Cc1cc(OC(C)(C)C(=O)O)c(C)cc1CNc1nc(-c2ccc(C(F)(F)F)cc2)cs1

nearest known ligand 0.50

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 13/20 0.50
PPARA Q07869 13/20 0.50
PPARG P37231 8/20 0.50
GSTO1 P78417 1/20 0.46
ALDH1A1 P00352 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
WNT3A P56704 1/20 0.41
TRPA1 O75762 1/20 0.41
TRPV4 Q9HBA0 1/20 0.41
SIRT5 Q9NXA8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2932340 0.92 ALDH1A1 (0.46) PPARDPPARAPPARGGSTO1ALDH1A1
SCHEMBL2906603 0.87 PPARD (0.48) PPARDPPARAPPARGGSTO1ALDH1A1
SCHEMBL2901181 0.86 PPARD (0.47) PPARDPPARAPPARGGSTO1ALDH1A1
SCHEMBL2900976 0.85 PPARD (0.47) PPARDPPARAPPARGGSTO1ALDH1A1
SCHEMBL2903594 0.84 PPARD (0.49) PPARDPPARAPPARGGSTO1ALDH1A1
SCHEMBL2906629 0.82 PPARD (0.48) PPARDPPARAPPARGGSTO1ALDH1A1
SCHEMBL2904024 0.81 PPARD (0.57) PPARDPPARAPPARG
SCHEMBL2903604 0.79 PPARD (0.45) PPARDPPARAPPARGGSTO1ALDH1A1
SCHEMBL2906451 0.79 PPARD (0.44) PPARDPPARAPPARGGSTO1ALDH1A1
SCHEMBL4179705 0.78 PPARD (0.54) PPARDPPARAPPARGALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100048453-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2010-02-25 US claimed
EP-1951692-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2008-08-06 EP claimed
WO-2007056496-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2007-05-18 WO claimed
EP-1951692-B1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2010-08-18 EP disclosed
US-20100048453-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2010-02-25 US disclosed
US-20100048453-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2010-02-25 US disclosed
US-20100048453-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2010-02-25 US disclosed
EP-1951692-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2008-08-06 EP disclosed
WO-2007056496-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2007-05-18 WO disclosed
WO-2007056496-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR IRM LLC (BM) 2007-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048453-A1 OXAZOLE AND THIAZOLE PPAR MODULATOR PPARD, PPARG, PPARA PPARD 1/4885PPARA 3/4885PPARG 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.